Literature DB >> 14645534

While K-ras is essential for mouse development, expression of the K-ras 4A splice variant is dispensable.

Sarah J Plowman1, D James Williamson, Maureen J O'Sullivan, Jennifer Doig, Ann-Marie Ritchie, David J Harrison, David W Melton, Mark J Arends, Martin L Hooper, Charles E Patek.   

Abstract

In mammals, the three classical ras genes encode four highly homologous proteins, N-Ras, H-Ras, and the isoforms K-Ras 4A and 4B. Previous studies have shown that K-ras is essential for mouse development and that while K-ras 4A and 4B are expressed during development, K-ras 4A expression is regulated temporally and spatially and occurs in adult kidney, intestine, stomach, and liver. In the present study, the pattern of K-ras 4A expression was examined in a wide range of wild-type adult mouse tissues, and gene targeting was used to generate K-ras 4A-deficient mice to examine its role in development. It was found that K-ras 4A is also expressed in uterus, lung, pancreas, salivary glands, seminal vesicles, bone marrow cells, and cecum, where it was the major K-Ras isoform expressed. Mating between K-ras(tmDelta4A/+) mice produced viable K-ras(tmDelta4A/tmDelta4A) offspring with the expected Mendelian ratios of inheritance, and these mice expressed the K-ras 4B splice variant only. K-ras(tmDelta4A/tmDelta4A) mice were fertile and showed no histopathological abnormalities on inbred (129/Ola) or crossbred (129/Ola x C57BL/6) genetic backgrounds. The results demonstrate that K-Ras 4A, like H- and N-Ras, is dispensable for normal mouse development, at least in the presence of functional K-Ras 4B.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14645534      PMCID: PMC309700          DOI: 10.1128/MCB.23.24.9245-9250.2003

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  32 in total

1.  GTP-dependent segregation of H-ras from lipid rafts is required for biological activity.

Authors:  I A Prior; A Harding; J Yan; J Sluimer; R G Parton; J F Hancock
Journal:  Nat Cell Biol       Date:  2001-04       Impact factor: 28.824

2.  Differential activation of the Rac pathway by Ha-Ras and K-Ras.

Authors:  A B Walsh; D Bar-Sagi
Journal:  J Biol Chem       Date:  2001-02-14       Impact factor: 5.157

3.  Dominant-negative caveolin inhibits H-Ras function by disrupting cholesterol-rich plasma membrane domains.

Authors:  S Roy; R Luetterforst; A Harding; A Apolloni; M Etheridge; E Stang; B Rolls; J F Hancock; R G Parton
Journal:  Nat Cell Biol       Date:  1999-06       Impact factor: 28.824

4.  Targeted genomic disruption of H-ras and N-ras, individually or in combination, reveals the dispensability of both loci for mouse growth and development.

Authors:  L M Esteban; C Vicario-Abejón; P Fernández-Salguero; A Fernández-Medarde; N Swaminathan; K Yienger; E Lopez; M Malumbres; R McKay; J M Ward; A Pellicer; E Santos
Journal:  Mol Cell Biol       Date:  2001-03       Impact factor: 4.272

5.  Targeted deletion of the H-ras gene decreases tumor formation in mouse skin carcinogenesis.

Authors:  K Ise; K Nakamura; K Nakao; S Shimizu; H Harada; T Ichise; J Miyoshi; Y Gondo; T Ishikawa; A Aiba; M Katsuki
Journal:  Oncogene       Date:  2000-06-15       Impact factor: 9.867

6.  Four human ras homologs differ in their abilities to activate Raf-1, induce transformation, and stimulate cell motility.

Authors:  J K Voice; R L Klemke; A Le; J H Jackson
Journal:  J Biol Chem       Date:  1999-06-11       Impact factor: 5.157

7.  Alternative splicing of the K-ras gene in mouse tissues and cell lines.

Authors:  Y Wang; M You; Y Wang
Journal:  Exp Lung Res       Date:  2001 Apr-May       Impact factor: 2.459

8.  Mutant K-ras enhances apoptosis in embryonic stem cells in combination with DNA damage and is associated with increased levels of p19(ARF).

Authors:  D G Brooks; R M James; C E Patek; J Williamson; M J Arends
Journal:  Oncogene       Date:  2001-04-19       Impact factor: 9.867

Review 9.  Blocking oncogenic Ras signaling for cancer therapy.

Authors:  A A Adjei
Journal:  J Natl Cancer Inst       Date:  2001-07-18       Impact factor: 13.506

Review 10.  The importance of being K-Ras.

Authors:  C A Ellis; G Clark
Journal:  Cell Signal       Date:  2000-07       Impact factor: 4.315

View more
  46 in total

1.  Noonan syndrome: clinical aspects and molecular pathogenesis.

Authors:  M Tartaglia; G Zampino; B D Gelb
Journal:  Mol Syndromol       Date:  2010-01-15

Review 2.  RAS-targeted therapies: is the undruggable drugged?

Authors:  Amanda R Moore; Scott C Rosenberg; Frank McCormick; Shiva Malek
Journal:  Nat Rev Drug Discov       Date:  2020-06-11       Impact factor: 84.694

3.  Identification of K-ras as the major regulator for cytokine-dependent Akt activation in erythroid progenitors in vivo.

Authors:  Jing Zhang; Harvey F Lodish
Journal:  Proc Natl Acad Sci U S A       Date:  2005-10-03       Impact factor: 11.205

4.  K-Ras4A splice variant is widely expressed in cancer and uses a hybrid membrane-targeting motif.

Authors:  Frederick D Tsai; Mathew S Lopes; Mo Zhou; Helen Court; Odis Ponce; James J Fiordalisi; Jessica J Gierut; Adrienne D Cox; Kevin M Haigis; Mark R Philips
Journal:  Proc Natl Acad Sci U S A       Date:  2015-01-05       Impact factor: 11.205

5.  The exon 8-containing prosaposin gene splice variant is dispensable for mouse development, lysosomal function, and secretion.

Authors:  Tsadok Cohen; Wojtek Auerbach; Liat Ravid; Jacques Bodennec; Amos Fein; Anthony H Futerman; Alexandra L Joyner; Mia Horowitz
Journal:  Mol Cell Biol       Date:  2005-03       Impact factor: 4.272

Review 6.  Extracellular-Regulated Kinases: Signaling From Ras to ERK Substrates to Control Biological Outcomes.

Authors:  Scott T Eblen
Journal:  Adv Cancer Res       Date:  2018-03-02       Impact factor: 6.242

7.  Evidence for aldosterone-dependent growth of renal cell carcinoma.

Authors:  Sharon King; Susan Bray; Sarah Galbraith; Lesley Christie; Stewart Fleming
Journal:  Int J Exp Pathol       Date:  2014-05-07       Impact factor: 1.925

8.  The distinct conformational dynamics of K-Ras and H-Ras A59G.

Authors:  Suryani Lukman; Barry J Grant; Alemayehu A Gorfe; Guy H Grant; J Andrew McCammon
Journal:  PLoS Comput Biol       Date:  2010-09-09       Impact factor: 4.475

9.  Kras is Required for Adult Hematopoiesis.

Authors:  Alisa Damnernsawad; Guangyao Kong; Zhi Wen; Yangang Liu; Adhithi Rajagopalan; Xiaona You; Jinyong Wang; Yun Zhou; Erik A Ranheim; Hongbo R Luo; Qiang Chang; Jing Zhang
Journal:  Stem Cells       Date:  2016-03-28       Impact factor: 6.277

10.  K-ras 4A and 4B mRNA levels correlate with superoxide in lung adenocarcinoma cells, while at the protein level, only mutant K-ras 4A protein correlates with superoxide.

Authors:  Richard J Calvert; Meghana Gupta; Anna Maciag; Yih-Horng Shiao; Lucy M Anderson
Journal:  Lung Cancer       Date:  2013-03-06       Impact factor: 5.705

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.